The control of crystal morphology in industrial crystallization is critical because it significantly affects efficiency of downstream processing (filtering, washing, and drying) and post-processing physicomechanical properties (bulk density, wettability and tableting behavior). In the case of pharmaceuticals, crystal morphology affects drug bioavailability and thus its therapeutic efficacy. Factors such as cooling rate, degree of supersaturation, agitation speed, agitation time, seeding and presence of impurities have been routinely used to engineer crystal morphology. However, the type of solvent chosen for a crystallization process tends to have the strongest influence. Identification of quantitative indices and associated software for tu...